Review
Copyright ©The Author(s) 2015.
World J Virology. Nov 12, 2015; 4(4): 323-342
Published online Nov 12, 2015. doi: 10.5501/wjv.v4.i4.323
Table 3 Performance characteristics of commercial methods for hepatitis B virus and hepatitis C virus detection and quantification
Assay (manufacture)MethodMeasurable range (IU/mL)Limit of detection IU/mL (using WHO HBV standard)Conversion factor (IU/mL to copies/mL)
HBV
Cobas ampliPrep/Cobas TaqMan HBV test v2.0 (Roche Diagnostics, California, United States)Semi-automated qPCR20-1.7 × 107205.82
Cobas TaqMan HBV test (for use with high pure system)Semi-automated real time PCR29-1.1 × 10765.82
Abbott real time HBV (Abbott Diagnostic, Chicago, United States)Automated real time PCR10-1 × 109103.41
Versant HBV 3.0 assay (Siemens Healthcare, United States)Branched DNA2000-1 × 10820005.6
HCV qualitative
Cobas Amplicor HCV v2.0 (Roche)Semiautomated RT-PCR5050-
Versant HCV RNA qualitative assay (TMA)Transcription-mediated amplification< 9.65-9.6-
Quantitative
Versant HCV RNA 3.0 (Siemens)Branched DNA7.7 × 1066155.2
Cobas Amplicor Monitor HCV v2.0 (Roche)Semiautomated RT-PCR5 × 1056002.7
Real time HCV (Abbott)Real time PCR1 × 107103.8
Cobas AmpliPrep/Cobas TaqMan (Roche)Automated real time PCR6.9 × 107433
High Pure/Cobas TaqMan (Roche)Semiautomated real time PCR3.9 × 108253